What Is a Wearable Dialysis Machine and How Does It Work?

A wearable dialysis machine is a miniaturized, body-worn device designed to clean the blood continuously throughout the day, rather than tethering a person to a large stationary machine for several hours at a time. It works on the same basic principle as conventional dialysis, filtering waste products like urea, creatinine, and phosphorus out of the blood, but does so using a tiny volume of cleaning fluid that gets recycled over and over through a sorbent cartridge. The technology has been under development since the early days of dialysis itself, and while no fully commercial wearable device exists yet, several prototypes have reached human trials with promising results.

How Conventional Dialysis Sets the Stage

Standard hemodialysis typically requires a patient to sit in a clinic or at home connected to a machine roughly the size of a small refrigerator for about four hours, three times a week. During each session, blood is drawn out through vascular access, run across a filter membrane where waste diffuses into a large volume of fresh dialysate fluid, and then returned to the body. A single session can use upward of 120 liters of purified water mixed into dialysate. The process is effective but disruptive: patients often feel drained afterward, face strict limits on fluid and food intake between sessions, and must organize their entire week around treatment slots.

Peritoneal dialysis, the other main option, uses the lining of the abdomen as a natural filter. Fluid is instilled into the abdominal cavity through a permanent catheter, left to dwell while waste diffuses across the peritoneal membrane, then drained and replaced. It can be done at home and even overnight, giving patients more daytime freedom, but still involves multiple fluid exchanges and several liters of disposable dialysate bags each day.

Both approaches share a core limitation: they are intermittent. Between treatments, toxins and excess fluid build up again, creating the characteristic peaks and valleys in blood chemistry that contribute to fatigue, cardiovascular stress, and dietary restrictions. A wearable device aims to flatten that roller coaster by running gently and continuously.

The Core Mechanics of a Wearable Hemodialysis Device

A wearable artificial kidney, or WAK, keeps the same fundamental exchange happening, blood on one side of a membrane, dialysate on the other, but shrinks every component and recycles the fluid. The device connects to the patient’s bloodstream through vascular access, draws blood at a much lower flow rate than a clinic machine, pushes it through a small hollow-fiber dialyzer worn on the body, and returns the cleaned blood. In one human trial, blood flow averaged roughly 59 mL per minute and dialysate flow about 47 mL per minute, both a fraction of the rates used in conventional machines.¹ A later FDA-authorized trial reported even lower flows, with blood and dialysate each averaging around 42–43 mL per minute over 24 hours of treatment.²

Those low flow rates are the key trade-off. A clinic machine pushes blood at 300–500 mL per minute and finishes in a few hours. A wearable device pushes blood gently but runs around the clock, so the total volume of blood treated over 24 hours can still be substantial. The clearance per minute is lower, but cumulative daily clearance can approach or match what a standard session achieves, without the dramatic fluid shifts that leave patients feeling wiped out.

Sorbent Cartridges and Dialysate Recycling

The single biggest engineering challenge in making dialysis wearable is the fluid. You cannot strap 120 liters of water to someone’s belt. The solution, pursued since the 1970s, is to reuse a small pool of dialysate by running it through sorbent materials that strip out the waste products picked up from the blood, effectively regenerating the fluid for another pass through the dialyzer.

Modern sorbent systems typically combine several layers. Urease, an enzyme, breaks down urea (the most abundant waste product) into ammonium and carbon dioxide. Zirconium-based sorbents then capture the ammonium and other ions. Activated charcoal adsorbs a range of organic toxins.³ The cleaned dialysate cycles back to the dialyzer, and the process repeats.

This recycling approach drops the total fluid volume from over a hundred liters down to less than a liter in some prototypes. But it introduces its own problems. The urease reaction releases carbon dioxide gas, which must be vented or captured before it re-enters the blood circuit. And the zirconium sorbents release sodium in exchange for the ammonium they absorb, which means sodium balance in the dialysate has to be carefully managed. These two issues, gas buildup and sodium release, have been persistent bottlenecks in sorbent-based wearable design.³

Another complication is competition. The sorbent materials and oxidation-based urea removal systems do not only react with waste. Nutrients in the blood, like amino acids and glucose, can interfere. One analysis estimated that about 7.7 grams of amino acids per session could compete with urea for removal, and for oxidation-based systems, glucose (around 24 grams) presents an even larger interference problem.⁴ Engineers are working on more selective sorbent materials to mitigate this.

What the Human Trials Have Shown

The most widely cited wearable artificial kidney prototype was developed by Victor Gura and colleagues. In an early clinical demonstration published in The Lancet, the device was tested on patients with end-stage kidney disease. Treatment ran for up to eight hours per patient. There were no significant cardiovascular changes, no dangerous shifts in electrolytes or acid-base balance, and no clinically meaningful destruction of red blood cells. Mean urea clearance was about 23 mL per minute and creatinine clearance about 21 mL per minute.¹ Two patients experienced clotting of the vascular access when anticoagulant doses were reduced, and one patient had a fistula needle dislodge, though built-in safety mechanisms prevented blood loss.

A subsequent 24-hour trial enrolled seven patients, of whom five completed the full treatment period. Over 24 hours, mean urea clearance was about 17 mL per minute and creatinine clearance about 16 mL per minute, lower numbers than the earlier shorter trial, reflecting the variability of sustained use.² Phosphorus clearance averaged roughly 15 mL per minute. The device also showed it could handle middle-sized molecules: a pilot study of the same technology found that beta-2-microglobulin, a larger protein fragment that accumulates in dialysis patients and contributes to joint problems, was cleared at about 11 mL per minute, with an average of roughly 100 mg removed per session. Phosphate removal averaged about 445 mg per session.⁵

Those clearance numbers are modest compared to a clinic machine running at full speed, but a conventional session only lasts a few hours. The wearable device, running at those lower rates for a full day, provides steady toxin removal that avoids the peaks and crashes of intermittent treatment. The phosphorus and middle-molecule clearance results are particularly interesting because conventional hemodialysis often struggles to remove enough of those substances, which is why dialysis patients frequently need phosphate-binding pills.

Wearable Peritoneal Dialysis

Not all wearable prototypes use blood circuits. Some are designed around peritoneal dialysis, where the abdominal cavity acts as the filter. A sorbent-assisted peritoneal dialysis system works by continuously recirculating dialysate through the peritoneal catheter in a tidal pattern: a portion of fluid is drained, passed through a sorbent cartridge to strip out the waste, and then returned to the abdomen. By keeping the dialysate fresh, this approach maintains a steep concentration gradient between blood and dialysate, which speeds up toxin removal compared to a static dwell where the fluid just sits in the abdomen getting progressively saturated.

One such system, tested in laboratory models, was designed in two versions: a bedside nighttime device weighing about 12 kilograms, and a smaller daytime wearable unit weighing roughly 2 kilograms that patients could carry with them for additional clearance during waking hours.⁶ The appeal of this approach is that it avoids the need for blood access entirely, sidestepping some of the clotting and bleeding risks that come with blood-based devices. It also builds on an established treatment modality that many patients already use, so the learning curve could be gentler.

Vascular Access Remains the Weak Link

For blood-based wearable devices, getting blood reliably in and out of the body is one of the hardest problems. Standard dialysis fistulas and grafts are surgically created connections between an artery and a vein, typically in the arm, and they work well for sessions where a nurse inserts large needles for a few hours. But a wearable device needs access that can stay connected for days or longer while the patient moves, sleeps, works, and showers.

Researchers have explored subcutaneous port systems as a potential solution. These are devices implanted under the skin with ports that can be accessed without traditional needles. Designs like the LifeSite and Dialock systems have shown some promise, allowing patients to remain mobile while connected to dialysis equipment.⁷ But infection risk is the persistent worry. Any point where the device meets the outside world is a potential entry for bacteria, and central venous catheters in dialysis patients already carry significant infection and hospitalization risk.⁷

One advantage of the lower flow rates in a wearable device is that the blood access can be smaller. Conventional hemodialysis needs high flows, meaning large-bore catheters. A wearable device operating at around 100 mL per minute could use much thinner catheters, potentially as small as 5-French single-lumen lines, which would be less invasive and easier to secure for extended wear.⁷ Clotting remains a concern even at lower flows, and researchers are investigating nanotechnology-based coatings for catheter surfaces that could reduce thrombosis without relying solely on blood-thinning drugs.

Handling Gas and Keeping the Blood Circuit Safe

When sorbent cartridges break down urea, the reaction produces carbon dioxide. If those gas bubbles make it into the blood return line, they can cause air embolism, a potentially life-threatening event. Wearable designs incorporate either mechanical air traps or degassing membranes to capture gas before it reaches the patient.⁸

The reliability of these safety systems deserves scrutiny. Research on conventional dialysis machines has shown that very small microbubbles, around 5 micrometers and up, can pass through standard air traps without triggering alarms. The number of bubbles increased with faster fluid flow rates, and no alarm sounded in any of the test runs.⁹ While that study examined conventional equipment, the finding is relevant to wearable designs because sorbent-based dialysate regeneration actively generates gas. Wearable devices will need bubble detection systems that are more sensitive than what exists in clinic machines today, especially since the patient may be asleep or otherwise unable to notice a problem.

Why Nothing Is on the Market Yet

The engineering obstacles are real but individually solvable. The reason wearable dialysis has not reached patients’ homes is that all the challenges must be solved simultaneously, in a single compact package, and certified safe for unsupervised daily use. A recent review cataloged the persistent barriers: device weight and bulk, ergonomic design, technical complexity, vascular access limitations, and inadequate remote patient monitoring.¹⁰

Regulatory hurdles add another layer. A wearable dialysis machine is not just a smaller version of an existing product; it introduces new risks that do not exist in clinic-based dialysis. Sorbent chemistry, continuous anticoagulation management, portable power supply reliability, and the challenge of remote monitoring all require novel safety standards. Regulators need evidence from extended clinical trials, not just 8- or 24-hour demonstrations, before clearing a device for daily home use. The path from promising prototype to approved product in medical devices of this complexity often stretches over a decade or more.

Battery technology is another underappreciated hurdle. Pumping blood and dialysate through a filter at even modest flow rates around the clock demands a power source that is simultaneously lightweight, long-lasting, and utterly reliable. A battery failure during treatment is not like a phone dying; it could leave a patient with blood in an extracorporeal circuit that begins to clot. Current prototypes have relied on rechargeable battery packs, but nobody has publicly demonstrated a wearable system running on batteries for multiple consecutive days outside a controlled research setting.

What Would Change for Patients

The potential quality-of-life shift is enormous. Wearable dialysis devices could allow patients to go about their normal daily activities while receiving treatment, and the continuous nature of the therapy could reduce or even eliminate the strict dietary and fluid restrictions that dominate the lives of people on conventional dialysis.¹¹ Fewer pills, fewer clinic visits, and the psychological relief of not being defined by a treatment schedule: these are the outcomes patients consistently say they want most.

The physiological benefits could be just as meaningful. Because continuous therapy avoids the rapid fluid removal that occurs during a four-hour session, cardiovascular stress should be lower. The large swings in blood pressure, the post-dialysis “crash” of fatigue and nausea, and the progressive heart damage that accumulates over years of intermittent treatment could all be mitigated. This is not just about comfort. Heart disease is the leading cause of death in dialysis patients, and a gentler treatment that keeps blood chemistry stable around the clock could, in theory, extend survival.

Implantable and Bioartificial Kidneys on the Horizon

Wearable devices are not the only frontier. Researchers are also developing fully implantable artificial kidneys that would sit inside the body, powered by blood pressure itself or by a small implanted pump, and bioartificial approaches that incorporate living kidney cells into a device to replicate functions no filter can perform, like hormone production and metabolic regulation. One recent overview described promising avenues including chip-based nanoporous filters, bioreactor technologies that use living cells, and even strategies to use the gut as a “third kidney” for waste excretion.¹²

These are further from clinical reality than wearable devices, but they represent a fundamentally different ambition: not just making dialysis portable, but making it invisible. An implanted device would require no external connections, no sorbent cartridge changes, no battery charging. It is a more complete solution, but it demands breakthroughs in biocompatible materials, long-term implant durability, and the ability to maintain living cells inside a machine inside a body. The timeline is measured in decades, not years.

Scaling Down for Children

One area where miniaturized dialysis technology could have an outsized impact is in treating very small patients. Conventional dialysis machines are designed for adult-sized blood volumes, and using them on newborns and infants creates serious challenges. The extracorporeal circuit itself can hold more blood than a small infant’s body can safely spare, sometimes necessitating blood transfusions just to prime the machine. Newer devices designed for neonates feature drastically reduced circuit volumes, smaller catheters, and finer volume control.¹³ The miniaturization lessons learned from wearable adult devices and from pediatric-specific machines are feeding into each other, since both demand that every component be as small and efficient as possible. If a wearable adult system can function with a total extracorporeal volume under 100 mL and blood flow rates of 40–60 mL per minute, that same engineering approach could someday benefit pediatric patients who currently have very few good options.

The Evolution from Concept to Prototype

Wearable dialysis is not a new idea. Researchers began projecting and even constructing wearable devices shortly after intermittent hemodialysis became an established treatment for chronic kidney failure. The development of hollow-fiber membranes was a critical early breakthrough: it allowed dialyzers to be made small enough to wear on the body rather than requiring a tabletop apparatus. Combining that with sorbent-based dialysate recycling drastically cut the volume of fluid needed. Over the decades, prototypes have been built around hemodialysis, hemofiltration (which uses more permeable membranes to remove waste by convection rather than diffusion), and peritoneal dialysis.¹⁴

What has changed recently is not the concept but the enabling technology. Better sorbent materials, more efficient miniature pumps, improved battery energy density, and advances in biocompatible coatings have collectively brought the idea closer to practical reality. Novel dialysis membranes made from new polymeric and inorganic materials are being developed to remove a broader range of toxins while resisting the membrane fouling that degrades performance over time. The convergence of these improvements is why multiple research groups and companies are now pursuing wearable prototypes simultaneously, after decades of the technology remaining largely theoretical.

1
The Lancet. A wearable haemodialysis device for patients with end-stage renal failure: a clinical demonstration
2
PubMed Central. A wearable artificial kidney for patients with end-stage renal disease
3
PubMed Central. The Revival of Sorbents in Chronic Dialysis Treatment
4
PubMed. Strategies for optimizing urea removal to enable portable kidney dialysis: A reappraisal
5
PubMed. Beta2-microglobulin and phosphate clearances using a wearable artificial kidney: a pilot study
6
PubMed. In vitro efficacy and safety of a system for sorbent-assisted peritoneal dialysis
7
Clinical Kidney Journal. Wearable artificial kidney and wearable ultrafiltration device vascular access—future directions
8
IntechOpen. Wearable Artificial Kidneys
9
PubMed. Air bubbles pass the security system of the dialysis device without alarming
10
PubMed Central. From Home to Wearable Hemodialysis: Barriers, Progress, and Opportunities
11
PubMed Central. Portable and wearable dialysis devices for the treatment of patients with end-stage kidney failure: Wishful thinking or just over the horizon?
12
American Journal of Kidney Diseases. The Future of Technology-Based Kidney Replacement Therapies: An Update on Portable, Wearable, and Implantable Artificial Kidneys
13
SpringerLink. New perspectives in pediatric dialysis technologies: the case for neonates and infants with acute kidney injury
14
Czech Technical Journal. WEARABLE ARTIFICIAL KIDNEY – EVOLUTION OF ITS CONCEPTS AND CURRENT STATE-OF-THE-ART